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ABSTRACT
The cellular prion protein (PrPC) whose conformational misfolding
leads to the production of deadly prions, has a still-unclarified cellular
function despite decades of intensive research. Following our recent
finding that PrPC limits Ca2+ entry via store-operated Ca2+ channels in
neurons, we investigated whether the protein could also control the
activity of ionotropic glutamate receptors (iGluRs). To this end, we
compared local Ca2+ movements in primary cerebellar granule
neurons and cortical neurons transduced with genetically encoded
Ca2+ probes and expressing, or not expressing, PrPC. Our
investigation demonstrated that PrPC downregulates Ca2+ entry
through each specific agonist-stimulated iGluR and after
stimulation by glutamate. We found that, although PrP-knockout
(KO) mitochondria were displaced from the plasma membrane,
glutamate addition resulted in a higher mitochondrial Ca2+ uptake
in PrP-KO neurons than in their PrPC-expressing counterpart. This
was because the increased Ca2+ entry through iGluRs in PrP-KO
neurons led to a parallel increase in Ca2+-induced Ca2+ release via
ryanodine receptor channels. These data thus suggest that PrPC
takes part in the cell apparatus controlling Ca2+ homeostasis, and
that PrPC is involved in protecting neurons from toxic Ca2+
overloads.
KEY WORDS: Neuron, Prion protein, Ca2+ homeostasis, Glutamate,
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INTRODUCTION
A conformational remodeling of the cellular prion protein (PrPC)
leads to the production of prions, the infectious particles causing
fatal transmissible spongiform encephalopathies or prion diseases
(Prusiner, 1998). The physiological function of PrPC – which is
linked to the external side of the plasma membrane (PM) – remains,
however, elusive, despite the many suggestions that PrPC is
intimately involved in processes protecting against cell damage
and death by triggering beneficial signals either by itself or as part of
multi-protein surface receptor complexes (Roucou et al., 2004;
Westergard et al., 2007; Linden et al., 2008).
Based on the notion that Ca2+ signaling and PrPC share functional
versatility and can both promote cell survival and death (Sorgato
and Bertoli, 2009), we have investigated on the capacity of PrPC to
regulate neuronal Ca2+ homeostasis. A close link between Ca2+
signaling and PrPC has already been observed in animal and
cell models of prion infection, showing, for example, impairment of
Ca2+-dependent neuronal excitability and synaptic plasticity
(reviewed in Peggion et al., 2011). The role of PrPC in Ca2+
homeostasis is further supported by comparing wild-type (WT)
and PrP-knockout (PrP-KO) hippocampal paradigms, indicating
that the absence of PrPC altered excitatory and inhibitory
neurotransmission and spatial learning (Collinge et al., 1994;
Mallucci et al., 2002; Criado et al., 2005; Powell et al., 2008).
These studies also showed that PrPC prevented potentially toxic
Ca2+ load mediated by the N-methyl-D-aspartate (NMDA)
receptors (NMDARs), following interaction with the receptor
regulatory subunit GluN2D (also known as GRIN2D)
(Khosravani et al., 2008a), and by modulating the affinity for
the co-agonist glycine in a copper ion-dependent manner
(You et al., 2012). Seemingly, NMDARs were also implicated
in the depressive-like behavior and reduced pain threshold
observed in PrP-KO mice (Gadotti and Zamponi, 2011; Gadotti
et al., 2012). Together with the α-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid (AMPA)- and kainate-responsive
receptors (AMPARs and kainateRs), NMDARs belong to the
glutamate-gated unselective (Na+/Ca2+) ionotropic receptor
(iGluR) channel family. iGluRs mediate the majority of rapid
excitatory synaptic responses in the mammalian central nervous
system (Ozawa et al., 1998), and are closely involved in models
of learning and memory such as long-term potentiation (LTP)
and long-term depression (LTD) (Malenka and Bear, 2004;
Henley and Wilkinson, 2013). Thus, the action of PrPC on
NMDARs was interpreted to prevent glutamate damage after
neuronal hyper-excitation, and correlates well with the increased
vulnerability observed in PrP-KO mice subjected to NMDA-
(and kainate-)induced excitotoxicity (Rangel et al., 2007), as
well as following epileptic seizures (Walz et al., 1999) or brain
ischemia (Spudich et al., 2005).
In light of these premisses, we inspected the ability of PrPC to
affect iGluR-induced Ca2+ movements in different domains
of cerebellar granule neurons (CGNs). To this end, we used
genetically targeted Ca2+-sensitive probes in primary CGN
cultures expressing, or not, PrPC. Our results indicated that PrPC
functionally downregulates all iGluRs, and that the reduced Ca2+
influx attenuates the process of Ca2+-induced Ca2+ release (CICR)
under the conditions used, which in turn limits mitochondrial Ca2+
uptake. Some of these aspects also applied to cortical neurons. Our
data thus emphasize that the beneficial action of PrPC in neurons
extends beyond the PM by defending mitochondria from
dangerously high Ca2+ accumulations.Received 14 September 2016; Accepted 5 July 2017
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RESULTS
PrPC attenuates iGluR-mediated Ca2+ entry in CGNs and
cortical neurons
In light of the electrophysiological evidence showing that PrPC
restricts NMDAR-mediated Ca2+ currents in hippocampal slices
and neurons (Khosravani et al., 2008a; You et al., 2012), we used
Ca2+-sensitive aequorin (AEQ) probes to compare NMDA-induced
Ca2+ movements in specific domains of primary CGNs obtained
from co-isogenic murine lines with (PrP-Tg) or without (PrP-KO)
PrPC. Fig. 1 reports the kinetics of Ca2+ fluxes (Fig. 1A,B, upper
panels) and the peak response (Fig. 1A,B, lower panels), detected
by AEQ targeted to the inner PM subdomains (AEQpm) (Fig. 1A)
or the bulk cytosol (AEQcyt) (Fig. 1B). Data clearly show that the
absence of PrPC (black) enhanced Ca2+ peaks compared to those in
PrP-Tg CGNs (gray), both at the PM and in the cytosol (by more
than 100% and ∼25%, respectively). The sum of the Ca2+ load
during the first 100 s of Fig. 1A (upper panel) indicates that the Ca2+
accumulation over time in PM subdomains of PrP-KOCGNs is two-
fold higher (110.2±7.1 μM) than in PrP-Tg CGNs (54.3±2.5 μM)
(mean±s.e.m.). Collectively, these results underline that PrPC acts as
Fig. 1. PrPC downregulates Ca2+ uptake in
CGNs after activation of specific iGluR
types. PrP-Tg (gray) and PrP-KO (black)
CGNs were analyzed for Ca2+ responses
upon NMDA [in the absence of Mg2+ and
in the presence of NMDAR co-agonist
glycine (Gly), as indicated] (A,B) or AMPA
(C,D) stimulation, in plasma membrane
(PM)-subdomains (A,C) or in the bulk
cytosol (B,D), by use of genetically targeted
AEQpm and AEQcyt Ca2+ probes,
respectively. Upper panels, showing the
average kinetics of local Ca2+ transients,
and lower bar diagrams, reporting the
corresponding Ca2+ peaks, indicate that
NMDA and AMPA induced significantly
higher PM Ca2+ transients in PrP-KO than
in the PrP-Tg counterpart, by more than
100% and ∼80%, respectively. The higher
percentage difference observed in PM
subdomains after activation of NMDARs
than AMPARs might explain why a slight,
though significant, percentage difference
(by ∼25%) could be detected in cytosolic
Ca2+ levels between PrP-KO and PrP-Tg
CGNs only following NMDA addition
(for more details, see the text). Values are
expressed as mean±s.e.m., and the number
of replicates (i.e. different coverslips from
at least three primary CGN cultures prepared
on different days) is indicated inside each
diagram bar. *P<0.05, ***P<0.001,
****P<10−5 (Student’s t-test).
2737
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 2736-2746 doi:10.1242/jcs.196972
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
a modulator of NMDARs also in CGNs. Notably, activity of
NMDARs generated similar long-lasting and higher PM Ca2+
amount in primary PrP-KO cortical neurons than in PrP-Tg
counterparts (Fig. S1A).
Next, we investigated whether PrPC could control AMPA-
sensitive iGluRs. As shown (Fig. 1C), addition of AMPA generated
PM Ca2+ peaks that in PrP-KO neurons were ∼80% enhanced
compared to those in PrP-Tg CGNs. However, no significant
difference in cytosolic Ca2+ peaks was detected (Fig. 1D), in
contrast to what observed upon NMDA stimulation. In this respect,
it is to be noted that what is sensed by AEQpm in PMCa2+ hot spots
(Filadi and Pozzan, 2015) would not be expected to correspond to
the Ca2+ levels detected by AEQcyt. Indeed, not only does AEQcyt
monitor the average bulk cytosolic Ca2+, but also diverse cytosolic
Ca2+ levels may arise only when the corresponding Ca2+ difference
in PM subdomains is above a given threshold. This contention is
further corroborated by the calculated sum of the Ca2+ load over the
time-to-peak period in PrP-KO CGNs compared to the PrP-Tg
counterpart, which resulted in three-fold greater Ca2+ amounts
following stimulation by NMDA (29.7±1.1 μM in PrP-KO CGNs;
9.9±1.3 μM in PrP-Tg CGNs; P<0.001), and less than two-fold
greater after AMPA (23.7±2.1 μM in PrP-KO CGNs; 13.1±1.5 μM
in PrP-Tg CGNs; P<0.001) addition. PM Ca2+ transients of much
smaller amplitude were observed upon kainate addition, and yet
again they were significantly lower in PrP-Tg than in PrP-KOCGNs
(data not shown).
Possible mechanisms for PrPC regulation of NMDARs and
AMPARs in CGNs
A major way to regulate the function of NMDARs and AMPARs is
via the reversible phosphorylation of their subunits (Lussier et al.,
2015). NMDARs, for example, are obligatory heterotetramers,
comprising two GluN1 (also known as GRIN1) subunits and two
GluN2A-D/GluN3A-B subunits (Paoletti et al., 2013). Of those,
GluN2A and GluN2B harbor Tyr residues at seven different
positions that can be phosphorylated by the Src family kinase (SFK)
member Fyn. Of these, phosphorylation of Tyr1472 (positioned in
GluN2B subunits) is necessary for preventing endocytosis of
NMDARs and for stabilizing the receptor in synaptic membranes
(Nakazawa et al., 2001; Trepanier et al., 2012). Thus, because we
have shown that PrPC constitutively downregulates Fyn in CGNs
(De Mario et al., 2015), NMDAR-induced PM Ca2+ fluxes were
analyzed in the presence of the SFK inhibitor saracatinib, or the less-
specific kinase inhibitor PP2, to understand whether the PrPC–Fyn
link controlled NMDARs. Fig. 2 reports that saracatinib (Fig. 2B)
and, to a greater extent, PP2 (Fig. 2C) reduced PM Ca2+ peaks in
both CGN genotypes. Both inhibitors, however, were unable to
abrogate the Ca2+ peak difference observed in their absence
(Fig. 2A). This result indicates that SFK and non-SFK members
may stabilize NMDARs on theCGNPMand/or regulate the receptor
function (Lussier et al., 2015), but that their activity cannot account
for the difference in NMDAR-mediated Ca2+ fluxes observed in the
two genotypes. Next, in light of the recently proposed axis
between PrPC and Ca2+/calmodulin-dependent protein kinase II
(CaMKII) (Haas et al., 2016), and the notion that CaMKII controls
NMDAR recycling by phosphorylating GluN2B subunits (on
Ser1303) (Lussier et al., 2015), we examined whether a different
basal active state of CaMKII (on the Thr286 autophosphorylation
site) could account for the dissimilar Ca2+ entry observed in the two
CGNgenotypes. This analysis, however, showed comparable results
in PrP-Tg and PrP-KO CGNs (Fig. S2A). Taken together, obtained
results suggest that other (Fyn- and CaMKII-independent)
Fig. 2. The difference in the NMDA-induced PM Ca2+ peak between PrP-Tg and PrP-KO CGNs does not depend on the activity of SFK members.
PrP-Tg (gray) and PrP-KO (black) CGNs were analyzed for Ca2+ fluxes in PM subdomains, by use of the AEQpm probe, after NMDA stimulation in the
presence of the SFK-inhibitor saracatinib (sara) (B), the less-specific kinase inhibitor PP2 (C) or the vehicle DMSO (0.01% v/v) (A). Upper panels report the
average kinetics of AEQpm-detected Ca2+ transients in PM-subdomains, while lower bar diagrams report the corresponding Ca2+ peaks, showing that both
saracatinib and (to a larger extent) PP2, decrease NMDA-induced PM Ca2+ peaks in both PrP-Tg and PrP-KO CGNs, without, however, abrogating the
difference observed in DMSO-treated CGNs. Values are expressed as mean±s.e.m., and the number of replicates (i.e. different coverslips from at least three
primary CGN cultures prepared on different days) is indicated inside each diagram bar. ***P<0.001 (Student’s t-test).
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mechanisms could play a prominent role in the regulation of the
receptor metabolism and/or activity by PrPC.
Phosphorylation events on tetrameric AMPAR-forming GluR1–
GluR4 (also known as GRIA1–GRIA4) subunits play a key role in
modulating the receptor properties and trafficking (Lee et al., 2010;
Huganir and Nicoll, 2013; Diering et al., 2016). In particular,
CaMKII and cAMP-dependent protein kinase (PKA) affect the
conductance (Barria et al., 1997; Kristensen et al., 2011) and
opening probability (Blackstone et al., 1994; Banke et al., 2000) of
AMPAR channels by acting on Ser831 and Ser845 of the GluR1
subunit, respectively. PKA-mediated Ser845 phosphorylation,
however, also promotes GluR1 insertion into the PM (Diering
et al., 2016). On this basis, after assessing that PrP-Tg and PrP-KO
CGNs contained equal amounts of GluR1 (data not shown), we
investigated on the phosphorylation state of Ser831 and Ser845
under basal conditions. Of them, Ser831, as expected, had equal
(CaMKII-dependent) phosphorylation levels in the two neuronal
types (Fig. S2B), whereas Ser845 was more highly phosphorylated
in PrP-KOCGNs (Fig. S2C). According to Song et al. (2013), a way
to enhance PKA activity is via extracellular signal-regulated kinase 1
and 2 (ERK1/2; also known as MAPK3 andMAPK1, respectively),
which phosphorylate and inhibit the cAMP-hydrolyzing enzyme
phosphodiesterase (PDE). Interestingly, we found that PrP-KO
CGNs had ∼50% more active ERK1/2 than PrP-Tg counterparts
under basal conditions (Fig. S2D). This result implies that, in
accordance with previous studies comparing WT and PrP-KO
organotypic retinal explants (Chiarini et al., 2002), PrP-KO CGNs
harbor higher cAMP, and consequently higher active PKA, levels.
To experimentally verify the consequences of the latter result, we
monitored GluR1 expression at the PM through a surface
biotinylation assay under basal conditions. This approach showed
that the surface expression of GluR1 was ∼70% more abundant in
PrP-KO neurons than in PrP-Tg CGNs (Fig. 3), indicating that an
enriched presence of the receptor at the PM could have contributed to
the higher AMPAR-mediated Ca2+ entry observed in PrP-KO CGNs.
Thecomplex regulation byPrPCofmitochondrial Ca2+ uptake
in CGNs
Finely tuned mitochondrial Ca2+ transients serve to stimulate
pyruvate dehydrogenase and other enzymes of the tricarboxylic acid
cycle, which provide reducing equivalents necessary for ATP
production by the oxidative phosphorylation process (Glancy and
Balaban, 2012). Excessive mitochondrial Ca2+ may, however,
threaten the life of the cell through a Ca2+-dependent permeability
change of the inner mitochondrial membrane, which collapses the
membrane potential and releases ATP and other key molecules from
the matrix, and pro-apoptotic factors from the intermembrane space
(Bernardi et al., 2015).
PrPC limits mitochondrial Ca2+ uptake after glutamate addition
In light of the above notions, we used an AEQ probe targeting the
mitochondrial matrix (AEQmit) to analyze the influence of PrPC
over mitochondrial Ca2+ uptake. Surprisingly, in spite of the
smaller PM Ca2+ entry observed in PrPC-expressing CGNs after
addition of each iGluR agonist (NMDA or AMPA), the same
protocols generated a higher (∼10% with NMDA, and ∼70% with
AMPA) mitochondrial Ca2+ peak in PrP-Tg CGNs than in PrP-KO
neurons (Fig. 4).
It is important to note that ablation of the PrP-encoding gene did not
alter aspects ofmitochondria directly implicated inCa2+ accumulation
(Fig. S3), for example, the magnitude of the mitochondrial
membrane potential (Δψm) (Fig. S3A), and the expression level of
the channel-forming subunit of the mitochondrial Ca2+ uniporter
(MCU) (Fig. S3B), both of which were independent of the CGN
genotype. Equally independent was the total mitochondrial
density estimated according to: (1) a western blotting-mediated
quantification of mitochondrial succinate dehydrogenase subunit
A (SDHA) (Fig. S3C); (2) transmission electron microscopy
(TEM) assessing the number of mitochondria (Fig. S3D); and (3)
immunocytochemistry tracking the outer membrane component
TOM20 (also known as TOMM20) (data not shown).
However, a closer analysis of ultra-thin CGN sections
unexpectedly revealed that the average distance of mitochondria
from the PM was ∼40% larger in PrP-KO than in PrP-Tg neurons
(Fig. 5). Mitochondria accumulate Ca2+ from different sources
depending on the cell type (Filadi and Pozzan, 2015). A major
source of mitochondrial Ca2+ in neurons is the extracellular space
(Murgia and Rizzuto, 2015) through the activity of PM Ca2+
channels (here iGluR channels). Data in Figs 4 and 5 thus support the
possibility that, despite each iGluR delivering a smaller PM Ca2+
quantity in PrP-Tg than in PrP-KO CGNs (Fig. 1A,C), Ca2+ uptake
by mitochondria of PrP-Tg CGNs was favored because of their
closer proximity to the PM.
We then examined neurons exposed to glutamate, the
physiological agonist for all GluRs (i.e. both ionotropic and
metabotropic receptors). As predicted from the simultaneous
activation of all iGluRs, use of AEQpm showed that glutamate
addition elicited higher peak Ca2+ transients than with each agonist
(NMDA or AMPA) alone in CGNs of either genotype (Fig. 6A;
compare with Fig. 1A,C). Furthermore, and different from what is
observed upon stimulation by NMDA or AMPA, exposure to
glutamate also led to a higher (by ∼40%) Ca2+ uptake in
mitochondria of PrP-KO neurons compared to PrP-Tg
Fig. 3. PrPC downregulates the plasma membrane localization of the
GluR1 subunit of AMPARs. Cell surface proteins were biotinylated in intact
PrP-Tg and PrP-KO CGNs, and precipitated from cell lysates (300 µg of total
proteins) using streptavidin-coated magnetic beads (see details in Materials
and Methods). After elution, biotinylated proteins (‘surface’ proteins, left-upper
panel), and proteins (10 µg) from cell lysates not subjected to the precipitation
step (‘total’ proteins, left-lower panel), were analyzed by western blotting with
the anti-GluR1 Ab. Western blots on the left are representative of six
independent experiments (i.e. using cultures prepared in different days), while
the bar diagram (right panel) reports the densitometric analysis of biotinylated
GluR1 bands normalized to the corresponding total GluR1 immunosignal (after
a first normalization of each immunosignal to the optical density of the
respective Coomassie-stained lane; see Material and Methods). By
diminishing the (PKA-dependent) phosphorylation of the AMPAR subunit
GluR1 at Ser845 (see Fig. S2C), PrPC also diminishes the here-shown
presence of (GluR1-containing) receptors at the cell surface that likely
contribute to the smaller AMPAR-mediated Ca2+ influx observed in PrP-Tg
CGNs compared to PrP-KO counterparts (see Fig. 1C). Data were normalized
to the values obtained with PrP-Tg samples and are expressed as mean±
s.e.m. *P<0.05 (Student’s t-test).
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counterparts (Fig. 6B). This result is reinforced by the similar
response of mitochondria in each CGN type when treated with all
iGluR agonists NMDA and AMPA added together (Fig. 6C) or of
glutamate-stimulated cortical neurons (Fig. S1B). We interpreted
these results as reflecting the significantly higher Ca2+ entry in
PrP-KO than in PrP-Tg neurons (Fig. 6A), but also a different
endoplasmic reticulum (ER) Ca2+ discharge, possibly through
channels responsive to metabotropic glutamate receptor (mGluR)-
produced inositol 1,4,5-trisphosphate (IP3) (Ribeiro et al., 2010),
given the close coupling between ER andmitochondrial membranes
(Rizzuto et al., 1998; Rowland and Voeltz, 2012).
To understand the specific ER contribution to mitochondrial Ca2+,
CGNs were then treated with 3,5-dihydrohyphenylglycine (DHPG),
a synthetic agonist of group I mGluRs (mGluR1 and mGluR5). This
protocol (Fig. S4A, gray line and gray bar), or the addition of
glutamate in the absence of external Ca2+ (data not shown),
produced only a negligible mitochondrial Ca2+ uptake in PrP-Tg
CGNs, with no appreciable difference between PrP-Tg and PrP-KO
CGNs (data not shown). A similar sluggish response was observed
under depolarizing conditions (in the presence of 125 mMKCl, data
not shown) to allow voltage-gated Ca2+ channels to deliver the
external Ca2+ apparently necessary to stimulate phospholipase C
under this condition (Masgrau et al., 2001). In contrast, cortical
neurons effectively responded to DHPG (Fig. S4A, black line and
black bar), as well as to glutamate in the absence of external Ca2+
(data not shown). The different response of CGNs and cortical
neurons to DHPG prompted us to analyze their mGluR5 content. As
expected, PrP-Tg and PrP-KO CGNs expressed extremely low
amounts of this receptor, in contrast to the much higher mGluR5
abundance detected in cortical neurons (Fig. S4B).
PrPC downregulates CICR
In light of the results indicating that IP3-sensitive channels
contributed minimally to mitochondrial Ca2+ accumulation in
Fig. 4. Mitochondria of PrP-KO
CGNs accumulate less Ca2+ than
PrP-Tg CGNs after activation of
NMDARs or AMPARs. CGNs were
analyzed for mitochondrial Ca2+
responses upon NMDA (A) or
AMPA (B) stimulation, by means of
the AEQmit probe targeting the
mitochondrial matrix. Upper and lower
panels, reporting the average kinetics
of Ca2+ transients and the
corresponding Ca2+ peak values,
respectively, indicate that, following
both stimuli, PrP-Tg mitochondria
accumulate more Ca2+ than the
PrP-KO counterpart. Values are
expressed as mean±s.e.m., and the
number of replicates (i.e. different
coverslips from at least three primary
CGNs cultures prepared on different
days) is indicated inside each
diagram bar. *P<0.05, ****P<10−5
(Student’s t-test).
Fig. 5. PrP-KOmitochondria aremore distant from the PM than PrP-Tgmitochondria.Ultra-thin (80 nm) CGN cross-sections were analyzed by transmission
electron microscopy (TEM). Representative TEM micrographs from PrP-Tg and PrP-KO neurons are reported in the left panels, in which some mitochondria are
indicated by yellow arrowheads. The bar diagram on the right reports the quantification of the mitochondria–PM distance, calculated as the average distance
between the center of mitochondria and the closest rim of the PM, showing that the mitochondria–PM distance is higher in PrP-KO than in PrP-Tg CGNs. The
analysis was carried out on a total of 16 randomly collected EM images for each CGNs genotype, comprising four technical replicates (i.e. different EM specimen)
for each of the four performed biological replicates (i.e. different primary CGNs cultures); values are expressed as mean±s.e.m. Scale bar: 1 µm. **P<0.01
(Student’s t-test).
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glutamate-stimulated CGNs, we considered whether CICR could be
responsible for the higher Ca2+ transients observed in PrP-KO
mitochondria. CICR is mediated by ryanodine receptor (RyR)
channels after activation by external Ca2+ entry, and plays an
important role in excitable cells by discharging Ca2+ from the ER/
sarcoplasmic reticulum, promoting mitochondrial uptake and
spreading the Ca2+ signal throughout the cell (Rizzuto et al.,
1998; Berridge, 2002, 2006; Rowland and Voeltz, 2012).
After assessing that equal (type 2) RyR amounts were present in
both CGN genotypes (data not shown), glutamate-induced
mitochondrial Ca2+ uptake was monitored in the presence of
ryanodine concentrations (50 μM) that are known to inhibit RyRs
(Sutko et al., 1997). As reported in Fig. 7, ryanodine slightly
reduced mitochondrial Ca2+ uptake in PrP-Tg CGNs (compare gray
lines and bars of Fig. 7A and Fig. 7B) while the strong action on
PrP-KO neurons (compare black lines and bars of panels Fig. 7A
and Fig. 7B) nullified the difference in Ca2+ peaks that was observed
in untreated CGNs. Collectively, these results demonstrate that, by
depressing Ca2+ entry, PrPC safeguards CGNs from CICR-mediated
mitochondrial Ca2+ overload.
DISCUSSION
The present work aimed at detailing the suggested involvement of
PrPC in neuronal Ca2+ homeostasis (Sorgato and Bertoli, 2009; Stys
et al., 2012; Peggion et al., 2017) by examining the possible
influence of PrPC on iGluR-mediated Ca2+ entry and glutamate-
induced Ca2+ release from the ER. Recombinant AEQs were
employed to compare local Ca2+ movements in primary neurons
expressing, or not expressing, PrPC. Notably, the sub-PM
localization of AEQpm strategically enables the probe to sense
iGluR-mediated transient Ca2+ hot spots (Filadi and Pozzan, 2015),
while the AEQmit position in the mitochondrial matrix provides
direct information on mitochondrial Ca2+ fluxes. Exploitation of
AEQs, apparently never employed before to follow PrPC-dependent
GluR-induced Ca2+ fluxes, helps to identify the precise sites at
which PrPC regulates neuronal Ca2+ homeostasis under
physiological, and possibly pathological, conditions.
Combination of the above approaches demonstrated that PrPC
prevents NMDAR-mediated Ca2+ overflow in CGNs and in cortical
neurons, in accord with data on hippocampal paradigms
(Khosravani et al., 2008a; You et al., 2012). However, we could
demonstrate that, in CGNs, PrPC downregulates AMPARs, and
likely also kainateRs, suggesting that the control of all iGluRs
underlies PrPC protective functions. Importantly, the insensitivity of
voltage-gated Ca2+ channels (VGCCs) to PrPC (De Mario et al.,
2015) excluded the possibility that they could contribute to the
different Ca2+ fluxes detected in the present work. Furthermore, we
have also found that AMPA-induced Ca2+ fluxes were insensitive to
the addition of nifedipine (data not shown), an inhibitor of L-type
VGCC mostly present in CGNs (Schramm et al., 1999).
In trying to identify the pathway(s) by which PrPC controls iGluR
activity, we considered the involvement of kinases such as Fyn and
CaMKII, which are known to modulate channel activity and/or
trafficking of NMDARs and AMPARs (Chen and Roche, 2007; Lu
and Roche, 2012; Lussier et al., 2015), and are also functionally
linked to PrPC (Mouillet-Richard et al., 2000; Schneider et al., 2003;
Monnet et al., 2004; Beraldo et al., 2011; Um et al., 2013; Raka
et al., 2015; Haas et al., 2016). However, because our experimental
setup was operationally unsuited to mimic the complex parameters,
including the actual and past activity of neurons, which may
ultimately control the activation of the enzymes and their
downstream effects (Henley and Wilkinson, 2013; Diering et al.,
Fig. 6. PrPC reduces cell Ca2+ entry and mitochondrial Ca2+ uptake in glutamate-stimulated CGNs. CGNs were analyzed for Ca2+ transients in PM
subdomains (A) and the mitochondrial matrix (B) after stimulation with glutamate (Glu, in the absence of Mg2+ and in the presence of Gly, as indicated), which
activates all ionotropic and metabotropic receptors. As evident from the average kinetics of Ca2+ transients (upper panels) and the corresponding Ca2+ peak
values (lower panels), PrP-KO CGNs displayed a higher level of Ca2+ entry from the extracellular space and higher mitochondrial Ca2+ uptake than PrP-Tg
neurons. A similar difference in mitochondrial Ca2+ transients was maintained when CGNs were treated with a mixture of all agonists to iGluRs (in the absence of
Mg2+ and in the presence of Gly) (C). Values are expressed as mean±s.e.m., and the number of replicates (i.e. different coverslips from at least three primary
CGNs cultures prepared on different days) is indicated inside each diagram bar. ****P<10−5 (Student’s t-test).
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2016), we analyzed whether PrPC could affect the basal state of the
enzymes – in analogy to our recently described PrP-dependent
downregulation of Fyn (De Mario et al., 2015) – and some
downstream targets.
Regarding NMDARs, the PrPC–Fyn link was particularly
attractive because several tyrosine residues serve as Fyn targets
and because phosphorylation of GluN2B Tyr1472 controls the
surface density of NMDARs (reviewed in Lussier et al., 2015).
Interestingly, the binding of Alzheimer’s disease (AD)-related Aβ
oligomers to PrPC hampers this process through the mediation of
mGluR5, and provokes synapse loss (Um et al., 2012, 2013). Here,
blocking Fyn activity with either the SFK-specific saracatinib or
the less-specific PP2 kinase inhibitor resulted in a lower NMDAR-
induced PM Ca2+ peak but did not abrogate the peak difference
between the two CGN genotypes. This evidence, and the finding
that PP2 was more effective than saracatinib in reducing NMDA-
evoked Ca2+ entry, underscores that phosphorylation by SFK
and non-SFK members may, indeed, upregulate NMDARs, but
definitively exclude that the different PM Ca2+ peak observed in
PrP-Tg and PrP-KOCGNs relies on the PrP-dependent regulation of
NMDAR residency at the PM through Fyn.
After excluding the possibility that CaMKII was involved in the
synaptic expression of CGN NMDARs (O’Leary et al., 2011; Chen
and Roche, 2007) because of the identical basal activation of the
enzyme detected in both CGN genotypes, we considered whether
PrPC could prevent NMDAR-mediated Ca2+ overload by favoring
the receptor desensitization process, particularly under a prolonged
agonist exposure (You et al., 2012; Stys et al., 2012). Explicitly, it has
been proposed that, by complexing with ambient copper ions [with
variable (femto/nanomolar) affinity at N-terminal sites (for a review
see Viles et al., 2008; Grande-Aztatzi et al., 2013)] and interacting
with the glycine-binding GluN1 subunit, PrPC lowers the affinity for
the co-agonist glycine, which otherwise would reduce – in a dose-
dependent manner – NMDAR desensitization and protract channel
opening (Mayer et al., 1989; Vyklický et al., 1990). Examination of
the KRB-based media (employed for Ca2+ measurements) by using
inductively coupled plasma atomic emission spectroscopy (Di Noto
et al., 1995) revealed a contamination by (total) copper ions of
∼500 nM. Therefore, one could tentatively speculate that this copper
ion concentration could still enable PrPC to counteract the effect of
non-physiological (high) concentrations of glycine, ultimately
resulting in attenuation of NMDA-driven Ca2+ influx.
To our knowledge, less information, if any, is available for the
PrP-dependent modulation of AMPARs we observed in CGNs. In
fact, limitation of AMPA-stimulated Ca2+ fluxes by PrPC contrasts
with previous data indicating that AMPAR currents, or AMPA-
mediated response to LTD stimuli, are independent of PrPC
(Khosravani et al., 2008a,b). Tentative explanations for this
discrepancy may rely on the different experimental settings, or on
the type and in vitro developmental stage of the examined
paradigms, given that the functional composition of iGluRs may
vary in different neurons and/or during development (Henley and
Wilkinson, 2013; Paoletti et al., 2013).Whatever the reason, our data
on CGNs not only enrich the list of PrPC-regulated receptors and
channels (Rangel et al., 2007; Beraldo et al., 2010, 2011; Carulla
et al., 2011; Lazzari et al., 2011; Watt et al., 2012; De Mario et al.,
2015; Fan et al., 2016), but – specifically to the crucial involvement
of AMPARs in LTP and LTD (Henley and Wilkinson, 2013) – cast
further significance on the involvement of PrPC in synaptic plasticity
(as hypothesized long ago, for example, by Collinge et al., 1994).
Regarding the mechanism enabling PrPC to regulate AMPARs,
no difference in the phosphorylation of Ser831 at the AMPAR
GluR1 subunit was observed in the two CGN genotypes under
unstimulated conditions (congruent with their similar CaMKII basal
activity). Conversely, we found that PrPC acted negatively on the
PKA-dependent phosphorylation of GluR1 Ser845, possibly
because the observed basal downregulation of ERK1/2 by PrPC
(Fig. S2D) limits ERK1/2-mediated inhibition of PDE (Song et al.,
2013). The likely lower cAMP amounts produced in the presence of
PrPC compared to when PrPC is absent (see Chiarini et al., 2002)
results, therefore, in less active PKA, consistent with our findings
that a reduced phosphorylation of GluR1 Ser845 leads to lower
amounts of GluR1 (and GluR1-containing AMPARs) at the
neuronal surface of PrP-expressing neurons (Fig. 3).
Of interest is that use of a targeted Ca2+ probe allowed us to
precisely monitor Ca2+ fluxes in the mitochondrial matrix, thus
Fig. 7. PrPC regulates Ca2+-induced Ca2+-release in CGNs.
CGNs were analyzed for mitochondrial Ca2+ transients following
stimulation with glutamate in the absence [but with the vehicle
DMSO 0.2% (v/v)] (A), or in the presence of ryanodine (Ryan,
50 µM, a concentration inhibitory to RyRs) (B). The average
kinetics of local Ca2+ transients, reported in the upper panels,
and the corresponding Ca2+ peaks of the lower bar diagrams,
show that RyR inhibition totally abrogates the difference
observed in controls, indicating that CICR was responsible for
the higher mitochondrial Ca2+ uptake in PrP-KO neurons
compared to that in the PrP-Tg counterpart. Values are
expressed as mean±s.e.m., and the number of replicates (i.e.
different coverslips from at least three primary CGNs cultures
prepared on different days) is indicated inside each diagram bar.
***P<0.001 (Student’s t-test).
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providing the novel information that PrPC may safeguard
mitochondria from glutamate-induced dangerous Ca2+ load. PrPC
accomplishes this task by downregulating iGluRs in such a way that
the generated Ca2+ influx seems almost incapable of activating
CICR in PrP-Tg CGNs. Interestingly, CICR is apparently the major
route exploited by CGNs to discharge ER Ca2+, given that these
neurons did not respond to DHPG, which activates IP3-producing
group 1 mGluRs.
Taken together, the presented data highlight that PrPC controls Ca2
+ homeostasis in different cell compartments of neurons following
exposure to physiological glutamate concentrations. Glutamate is the
major excitatory neurotransmitter responsible for learning and
memory (Malenka and Bear, 2004; Henley and Wilkinson, 2013),
which are based on cytosolic Ca2+ rise consequent to iGluR activity,
or glutamate-mediated Ca2+ discharge from internal stores. Clearly,
regulation of all GluRs must be extremely precise, and the present
work shows that PrPC contributes to the cell apparatus preventing
glutamate excitotoxicity, and excessive Ca2+ load therein, which
could switch a beneficial signal into one disrupting synapse
functions. Of relevance in this scenario, is the demonstration that
the influence of PrPC extends from the PM to mitochondrial
metabolism, because attenuation of the activity of all iGluRs by PrPC
limits CICR and mitochondrial Ca2+ uptake. In this way, PrPC could
preclude dysregulation of key functional aspects of mitochondria,
including the permeability of the inner membrane, which guarantees
the functional integrity of the organelle (Bernardi et al., 2015).
This notion is of particular importance in the context of
neurodegenerative processes involving glutamate and PrPC.
Indeed, impaired glutamate signaling is a major player in
neurodegenerative disorders (Lewerenz and Maher, 2015), while
PrPC not only causes fatal prion diseases following conformational
misfolding (Prusiner, 1998) but could also serve as a high-affinity
receptor for both prions (Resenberger et al., 2011) and AD-causing
Aβ oligomers (Laurén et al., 2009). One can envisage, therefore,
that the structure and/or the function of PrPC are compromised after
forming complexes with misfolded oligomers, and that, as
mimicked in part by our PrP-KO model, diversion from the native
protective function of PrPC contributes to neuronal pathogenesis.
Another interesting observation of this work, which also deserves
further elucidation, is the apparent capability of PrPC to control the
distribution of mitochondria in CGNs in such a way that
mitochondria of PrP-KO CGNs are more distant from the PM than
in PrP-Tg neurons. This fact could explain whymitochondria of PrP-
KO neurons took up less Ca2+ than PrP-Tg CGNs after activation of
a single iGluR type (NMDAR or AMPAR) (Fig. 4), although
more abundant extracellular Ca2+ entry was detected in the former
neuronal type (Fig. 1). Instead, when all iGluRs were stimulated
by glutamate, the resulting increased total Ca2+ flux (Fig. 6A)
activated CICR to a much larger extent in PrP-KO than in PrP-Tg
CGNs, which led to a higher mitochondrial Ca2+ uptake (Fig. 6B
and Fig. 7) despite the larger mitochondria–PM distance. Along
this line, one might assume that inhibition of CICR by ryanodine
resulted in a lower mitochondrial Ca2+ uptake in PrP-KO than in
PrP-Tg CGNs, as observed with NMDA or AMPA, alone. It is to
be noted, however, that as glutamate in the presence of ryanodine
elicited a much higher mitochondrial Ca2+ transient than that
recorded with iGluR agonists (compare Fig. 7B and Figs 4 and
6C), such an assumption is not necessarily well grounded.
Finally, our findings on PrPC-dependent mitochondria localization
nicely fit in the framework of the alleged neuroprotective PrPC
functions (see above). Indeed, pathological alterations of PrPC-related
signaling are likely to result in a localization of mitochondria too far
from active synapses to allow delivery of the ATP amount necessary
to satisfy the high energy demand of synapses.
MATERIALS AND METHODS
Animals
In this study, PrP-Tg and PrP-KO mice (lines Tg46 and F10, respectively)
were used. Both strainswere kindly provided by theMRCPrionUnit, London,
UK. PrP-Tg (Tg46) mice served as control because the expression of PrPC in
this strain was rescued over the PrP-KO (F10) genotype, thereby providing co-
isogenic mouse lines (Mallucci et al., 2002). In addition, PrP-Tgmice express
PrPC at the same level found inWTmice (Mallucci et al., 2002; Lazzari et al.,
2011). Experiments were carried out in accordance with European and Italian
(D.L. 26/2014) laws concerning the care and use of laboratory animals. The
institution of the authors has been accredited for the use of mice for
experimental purposes by the Italian Ministry of Health and by the Ethical
Committee of the University of Padova (authorization no. 13/2012).
Primary neuronal cultures
Primary cultures of CGNs and cortical neurons were prepared, cultured and
transduced with lentiviral particles as previously described (De Mario et al.,
2015), with minor modifications. Briefly, after seeding cells at the needed
density (∼9×105 and 6×105 onto poly-L-lysine-coated 13-mm coverslips for
luminometer and immunocytochemistry assays, respectively; ∼3×106 and
1.2×106 onto 35-mm poly-L-lysine-coated plates for western blotting and
fluorescence/transmission electron microscopy assays, respectively), cells
were maintained at 37°C in a humidified incubator with 5% CO2. Lentiviral
particles were added to cells 24 h after plating, and after an additional 24 h
cytosine arabinoside (0.04 mM for CGNs, and 0.01 mM for cortical
neurons, Sigma) was supplemented to impede proliferation of non-neural
cells. After a further 48 h (for CGNs), or 124 h (for cortical neurons),
primary cultures were subjected to experimentation. As already proven for
CGNs (Lazzari et al., 2011), the immunocytochemical analysis based on the
neuronal (microtubule-associated protein 2; MAP2) and astrocytic (glial
fibrillary acidic protein; GFAP) markers, revealed that primary cortical
neurons were >97% pure (data not shown).
Construction of lentiviral vectors for AEQs
To measure Ca2+ transients in specific neuronal compartments, lentiviral
vectors encoding AEQpm, AEQcyt or AEQmit were used (Lim et al., 2016).
Lentiviral vectors for AEQpm and AEQmit were generated by using an
AEQ mutant with reduced Ca2+ affinity allowing measurements of Ca2+
concentrations up to hundreds of micromolar, while a chimeric construct of
WTAEQ was used to generate the lentiviral vector for AEQcyt (Lim et al.,
2016). The expression and correct cellular localization of AEQs were
determined by immunocytochemistry approaches (De Mario et al., 2015).
Measurements of local Ca2+ fluxes
To measure Ca2+ transients in the cytosolic domains proximal to the PM
([Ca2+]pm), the cytosol ([Ca2+]cyt) and the mitochondrial matrix ([Ca2+]mit)
following stimulation of iGluRs or mGluRs, neurons were first incubated
(1 h, 37°C, 5% CO2) in Krebs-Ringer buffer (KRB; 125 mM NaCl, 5 mM
KCl, 1 mM KH2PO4, 1 mM MgSO4, 5.5 mM glucose, 20 mM HEPES,
pH 7.4) containing CaCl2 (1 mM, for AEQcyt and AEQmit) or EGTA
(100 µM, for AEQpm), and the AEQ cofactor coelenterazine (5 µM, Santa
Cruz Biotechnology, cat. no. sc-205904). After transferring coverslips to the
thermostatted chamber of a purpose-built luminometer, perfusion of
neurons varied according to the envisaged GluR stimulation. That is, if all
iGluRs were the simultaneous target, neurons were perfused (1 min) with
Mg2+-free (Ruppersberg et al., 1994) KRB (containing 1 mM CaCl2), and
then with either glutamate (100 μM, Sigma) plus the co-agonist glycine
(10 μM, Sigma), or a mixture of NMDA (50 μM, Sigma), AMPA (100 μM,
Tocris) and kainate (30 μM, Tocris) plus glycine (10 μM); in the case of a
single iGluR activation, the specific agonist, namely NMDA (plus 10 μM
glycine), AMPA or kainate (all at the above concentrations) was added
(KRB was Mg2+ free only with NMDA); when activating mGluRs
specifically, either DHPG (100 μM, Tocris) or glutamate in CaCl2-free
KRB was used. If needed, the specific-SFK inhibitor saracatinib (5 μM,
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Santa Cruz Biotechnology, cat. no. sc-364607) or the less-specific PP2
(10 μM Tocris, cat. no. 1407), both diluted in 0.01% (v/v) dimethyl
sulfoxide (DMSO), was present throughout the experiment starting from the
addition of coelenterazine, while ryanodine [50 μM in 0.2% (v/v) DMSO,
Tocris], at inhibitory concentrations to RyRs, was present from the
Mg2+-free perfusion step.
AEQ light emission was recorded using an in-house built luminometer,
equipped with a low-noise photo-multiplier coupled with an analog-to-
digital converter to a computer-assisted acquisition system (Ottolini et al.,
2014), at a 1 Hz sampling rate. At the end of each recording, cells were
perfused with KRB containing digitonin (50 µM, Sigma) and a saturating
Ca2+ concentration (10 mM), allowing the calibration of the recorded light
signal to the total AEQ content. The conversion of the light signal into Ca2+
concentration was carried out using the algorithm and the custom-made
software previously described (Brini et al., 1995; Montero et al., 1995).
Measurement of mitochondrial membrane potential
Tetramethylrhodamine methyl ester (TMRM, λexc=548 nm, λem=574 nm,
Molecular Probes) was employed to measure Δψm of CGNs. To this end,
experiments were carried out under basal conditions (i.e. the conditions used
for detecting Ca2+ fluxes in the organelle but in the absence of stimuli).
TMRM is permeable to the PM and, being a cation, it accumulates
electrophoretically into the matrix of respiring mitochondria (Scaduto and
Grotyohann, 1999). Coverslip images were collected using an inverted
microscope (Olympus IMT-2) equipped with a (75W) xenon lamp, a 16-bit
digital CCD camera (cooled by aMiromax system, Princeton Instruments), a
40× oil objective, and appropriate excitation and emission filters. Several
fields were acquired from each coverslip before and after the addition of
trifluorocarbonylcyanide phenylhydrazone (FCCP) (5 μM, Sigma), which,
by collapsing Δψm, induces the release of TMRM from mitochondria.
Images were analyzed with Image J software. Fluorescence density was
measured in mitochondria-rich regions and calculated as the difference
between the mean fluorescence density detected before and after FCCP
addition. TMRM fluorescence density was then reported as percentage of
the PrP-Tg mean value.
Transmission electron microscopy
We used TEM to quantify mitochondria in CGNs and their distance from the
PM. CGNs were fixed in glutaraldehyde [3.9% (w/v) in a sodium cacodylate
buffer, pH 7.4], and embedded in Epon 812 resin. Ultra-thin (80 nm) cross-
sections were cut with a microtome (UltratomeV, LKB), mounted on copper
grids, contrasted with uranyl acetate (1%) and lead citrate (1%), and
examined at a transmission electron microscope (Tecnai G2, FEI) operating
at 100 kV. Images were acquired with a digital camera (F114, Tvips) and a
dedicated software (TIA, FEI), and the density of mitochondria per area
units in soma and dendrites was calculated using the Image J software. The
mitochondria-PM distance was estimated (using the latter software) as the
shortest distance between the center of each mitochondrion and the rim of
the PM. To guarantee that mitochondria were randomly selected for
statistical analyses, 4 different cell preparations from each of the used 4
independent cultures were analyzed by TEM for either PrP-tG or PrP-KO
genotype. At least 70 mitochondria were generally measured in a single cell
preparation, and data were reported as the mean of the 16 replicates for an
individual CGN genotype.
Western blotting analysis
CGNswere incubated (1 h, 37°C, 5%CO2) inKRB supplementedwithCaCl2
(1 mM), and subsequently lysed in a buffer containing 10% (w/v) glycerol,
2% (w/v) sodium dodecyl sulfate (SDS), 62.5 mM Tris-HCl (pH 6.8), 1.8 M
urea, 5 mM Na3VO4, protease and phosphatase inhibitor cocktails (Roche).
After determining the protein concentration (Total Protein Kit, micro Lowry,
Peterson’s modification, Sigma), lysates were adjusted to an equal protein
concentration using reducing (50 mM dithiothreitol) Laemmli sample buffer.
After boiling (5 min), lysates were subjected to SDS-PAGE [10% (w/v)
acrylamide-N,N′-methylenebisacrylamide (37.5:1)] and electroblotted
onto nitrocellulose membranes (0.45 μm pore size, Biorad) to detect
SDHA, or onto polyvinyl-difluoride (PVDF) membranes (0.45 μm pore
size, Millipore) to detect MCU, mGluR5 that was phosphorylated or
not (on Ser831 or Ser845), the GluR1 subunit of AMPARs phosphorylated
or not (on Thr202/Tyr204), ERK1/2, and (auto) phosphorylated (on
Thr286) CaMKII. To verify equal loading and transfer, nitrocellulose
membranes were stained with Ponceau Red, while Coomassie Blue was
used to stain PVDF membranes. After de-staining, membranes were
incubated (1 h, room temperature) with a blocking solution [Tris-buffered
saline added with 0.1% (w/v) Tween-20 (TBS-T) and 3% (w/v) bovine
serum albumin (BSA)], followed by incubation (overnight,
4°C) with one of the following primary rabbit polyclonal antibodies
(pAbs) (dilution in parenthesis): anti-SDHA [Sigma cat. no. SAB1100429;
1:1000 in BSA 3% (w/v) added to TBS-T]; anti-MCU [i.e. to the channel-
forming MCU subunit, Sigma cat. no. HPA016480; 1:1000 in milk 5%
(w/v) added to TBS-T]; anti-mGluR5 [Millipore cat. no. ab5675; 1:2000 in
BSA 1% (w/v) added to TBS-T]; anti-GluR1 [Millipore cat. no. ab1504;
1:1000 in BSA 3% (w/v) added to TBS-T]; anti-phosphorylated CaMKII (on
Thr286) [Cell Signaling Tech. cat. no. 3361; 1:500 inmilk 5% (w/v) added to
TBS-T], the correct targeting of which was verified under depolarized
conditions that maximally activated CaMKII by Ca2+ (KCl being raised to
145 mM 2 min before cell lysis); anti-phosphorylated GluR1 (on Ser831)
[Millipore cat. n. ab5847; 1:1000 in milk 5% (w/v) added to TBS-T]; anti-
phosphorylated GluR1 (on Ser845) [Santa Cruz Biotechnology cat. no. sc-
135699; 1:500 in BSA 3% (w/v) added TBS-T]; anti-ERK1/2 [Cell
Signaling Tech., cat. no. 9102; 1:1000 in BSA 3% (w/v) added to TBS-T].
Detection of phosphorylated ERK1/2 was performed using a primary mouse
monoclonal Ab [Cell Signaling Tech. cat. no. 9106; 1:1000 in BSA 3% (w/v)
added to TBS-T]. After three washing steps (10 min each in TBS-T),
membranes were incubated (1 h, room temperature) with a horseradish
peroxidase-conjugated anti-rabbit-IgG, or anti-mouse-IgG secondary Ab
(Santa Cruz Biotechnology cat. no. sc-2004/2005). Immunoreactive bands
were visualized and digitalized by means of a digital Kodak Image Station,
using an enhanced chemiluminescence reagent kit (Millipore). For
densitometric analyses, band intensities were normalized to the optical
density of the corresponding lanes stained with Ponceau Red or Coomassie
Blue (Welinder and Ekblad, 2011). When analyzing GluR1 or ERK1/2
phosphorylation, samples were run in parallel in the same gel, and then
probed with either the Ab to the phosphorylated form or to the total protein;
the band intensity of the phosphorylated form was finally normalized to that
of the corresponding signal of total GluR1 or ERK1/2. All data are reported
as fraction of the mean values of PrP-Tg samples.
Cell surface biotinylation
At 96 h after plating, CGNs were washed twice with ice-cold KRB
supplemented with 1 mM CaCl2, and gently shaken (1 h, 4°C) in KRB
containing a membrane-impermeable biotin derivative (EZ-Link Sulfo-
NHS-LC biotin, Thermo Scientific, cat. no. 21335; 0.75 mg ml−1).
Unbound biotin was removed by extensive washings of neurons, first with
ice-cold KRB, and then (three times) with ice-cold glycine (20 mM)-
containing PBS. Cells were lysed using a lysis buffer containing 150 mM
NaCl, 1 mM EDTA, 50 mM Tris-HCl (pH 7.4), 1% (v/v) Triton X-100 and
a protease inhibitors cocktail (Roche); cell lysates [300 µg of total proteins,
determined by a bicinchoninic acid-based protein assay kit (Thermo
Scientific)] were centrifuged (16,000 g, 15 min, 4°C), and the supernatant
was incubated (overnight, 4°C) with streptavidin-coated magnetic beads
(Thermo Scientific, cat. no. 88816). After two washings in lysis buffer,
beads were collected using a magnetic rack (SureBeads, BioRad). After
elution with Laemmli sample buffer containing 200 mM dithiothreitol as
reducing agent, biotinylated proteins were separated by SDS-PAGE (4–15%
gradient acrylamide-N,N′-methylenebisacrylamide, PROTEAN TGX
precast electrophoresis gels, Bio-Rad), electroblotted onto PVDF
membranes and immunoprobed with the anti-GluR1 Ab (see above). To
determine total neuronal GluR1 amounts, lysates (10 µg) were analyzed as
hitherto described, except for omitting the addition of streptavidin-coated
magnetic beads. For densitometric analyses, band intensities were
normalized to the optical density of the corresponding Coomassie Blue-
stained lanes, and the band intensity of the biotinylated GluR1 form was
normalized to that of the corresponding total GluR1 signal. Data are
reported as fraction of the mean values of PrP-Tg samples.
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Statistical analysis
Values are reported as mean±s.e.m. Data analysis was performed as
described in detail in Lazzari et al. (2011). Statistics was based on two-
sample Student’s t-test, with P< 0.05 being considered statistically
significant (*P<0.05, **P<0.01, ***P<0.001, ****P<10−5).
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Figure S1. PrP
C
 attenuates Ca
2+
 entry after NMDAR activation and glutamate-induced mitochondrial 
Ca
2+
 transients in primary cortical neurons. The kinetics of Ca
2+ 
transients (upper panels) and the peak 
value of Ca
2+ 
responses (lower panels) demonstrate that in cortical neurons PrP
C
 (grey) reduced Ca
2+ 
accumulation in PM-subdomains after addition of NMDA (A), and mitochondrial Ca
2+ 
transients after 
addition of glutamate (Glu) (B) (both in the absence of Mg
2+
 and in the presence of NMDAR co-agonist 
glycine (Gly), as indicated), compared to the PrP-KO counterpart (black). Here and after, values are 
expressed as mean ± SEM, while the number of replicates is indicated inside each diagram bar. **p < 0.01; 
here and after, statistics were performed by the Student’s t-test, considering statistically significant a p-value 
< 0.05. Other details are as in the legend to Fig.s 1, 3 and 5. 
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Figure S2. PrP
C
 does not affect the basal phosphorylation state of CaMKII on Thr286 nor the 
phosphorylation of AMPAR-GluR1 subunit on Ser831, while it downregulates phosphorylation of 
GluR1 on Ser845, and of ERK 1/2 on Thr202/Tyr204. (A-D) Proteins (20 g) from PrP-Tg and PrP-KO 
CGN lysates were resolved by SDS-PAGE, electroblotted and probed with antibody (Ab) to phosphorylated 
(p) CaMKII (on Thr286) (A), or to pGluR1(on Ser831) and GluR1 (B), or to pGluR1(on Ser845) and GluR1 
(C), or to pERK 1/2 (on Thr202/Tyr204) and ERK 1/2 (D). Upper panels show Western blots (WB) for each 
genotype representative of at least 9 independent experiments (i.e., using cultures prepared in different days), 
while bar diagrams of the lower panels report the corresponding densitometric analyses. The optical density 
of pCaMKII immunoreactive bands was normalised to that of the corresponding Coomassie-stained lanes 
(A), while reliability of the anti-pCaMKII Ab was proved by the immunoreactive signal increase observed 
under depolarized conditions (KCl concentration raised to 145 mM) (upper-right panel), to allow Ca
2+
 entry 
and CaMKII maximal stimulation. After normalisation of all immunosignals to the corresponding 
Coomassie-stained lanes (see Materials and Methods), the optical density of pGluR1Ser831 (B), 
pGluR1Ser845 (C), and pERK 1/2 (D), bands was normalised to that of the corresponding total GluR1 and 
ERK 1/2 bands, respectively. Incapacity of PrP
C
 to regulate basal CaMKII activation (A) and (CaMKII-
dependent) phosphorylation of AMPAR-GluR1Ser831 (B) strongly suggests that the different Ca
2+ 
fluxes 
observed in the two PrP genotypes upon stimulation with NMDA (Fig.1A) or AMPA (Fig.1C) cannot be 
explained by a CaMKII-dependent change in NMDAR recycling and AMPAR biophysical properties, 
respectively. Conversely, by downregulating PDE-inhibiting active ERK 1/2 levels (D), PrP
C
 diminishes the 
(PKA-dependent) phosphorylation of AMPAR-GluR1Ser845 (C), which in turn lowers the presence of 
(GluR1-containing) receptors at the cell surface (see Fig. 3). All reported data were normalized to the values 
obtained with PrP-Tg samples. **p < 0.01; other details are as in the legend to Fig. S1. 
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Figure S3. The absence of PrP
C
 does not modify Ca
2+
-related mitochondrial parameters, nor the 
number of the organelles. (A, B) The amplitude of the mitochondrial membrane potential (Δψm) (A) and 
the expression of the Ca
2+
 uniport (MCU) (B) were determined using the potentiometric fluorophore TMRM 
and WB, respectively. (A) Upper panels report representative fluorescence micrographs of TMRM-loaded 
CGN under basal conditions. The lower bar diagram reports the relative TMRM fluorescence quantification 
(expressed as percentage of the mean value obtained for PrP-Tg samples), indicating that both neuronal types 
had similar Δψm magnitude. (B) The representative WB of PrP-Tg and PrP-KO CGN lysates (upper panels), 
probed with an Ab to MCU (i.e., to its channel-forming subunit), and the densitometric analyses (lower 
panel) – in which the MCU immunosignal was normalized to the optical density of the corresponding 
Coomassie-stained lanes and reported as fraction of the PrP-Tg mean value – clearly indicate that similar 
MCU amounts were present in both neuronal types. (C, D) Also the number of mitochondria was found to be 
similar in PrP-Tg and PrP-KO CGN. Indeed, no significant difference between the two genotypes was 
observed in: (i), the expression of the mitochondrial marker (inner membrane protein) succinate 
dehydrogenase-A (SDHA) (C), as shown by the representative WB (upper panels) and the corresponding 
densitometric analysis (lower panel), in which the SDHA immunosignal was normalized to the optical 
density of the corresponding Ponceau red-stained lanes; (ii), the mitochondrial density, assessed by 
transmission electron microscopy (TEM) analysis (D), as shown by the representative TEM micrographs 
(upper panels) and the quantification of the number of mitochondria per unit area (lower panel). Scale bar, 
10 μm in A; 1 μm in D. Other details are as in the legend to Figs. S1 and S2. 
J. Cell Sci. 130: doi:10.1242/jcs.196972: Supplementary information
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
Figure S4. mGluRs do not substantially contribute to glutamate-mediated mitochondrial Ca
2+
 
transients in CGN. (A) DHPG, the specific agonist to mGluR1 and mGluR5, induced only minimal 
mitochondrial Ca
2+
 transients in CGN and a much higher Ca
2+
 transients in cortical neurons, as indicated by 
the average traces and the corresponding mean Ca
2+
 peaks (bar diagrams, insets). (B) WB analysis of PrP-Tg 
and PrP-KO CGN and PrP-Tg cortical neurons (all run in duplicate) indicated that mGluR5 was robustly 
expressed in cortical neurons, but only slightly present in CGN (upper panel). All lysates were loaded in 
similar amounts, as shown by the corresponding lanes stained with Coomassie blue (lower panel). ***p < 
0.001; other details are as in the legend to Figs. S1 and S2. 
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